NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Balance Sheet
OSL:NEXT • NO0010629108
Current stock price
5.399 NOK
+0.2 (+3.83%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.29M | 62.91M | 67.75M | 69.30M | 102.71M | |||
| Receivables | 768.00K | 3.32M | 17.19M | 12.59M | 11.80M | |||
| Inventories | 25.40M | 35.39M | 23.13M | 22.93M | 18.99M | |||
| Other Current Assets | 8.95M | 10.21M | 2.56M | 2.06M | 7.70M | |||
| Total Current Assets | 43.41M | 108.76M | 110.63M | 106.89M | 141.19M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.66M | 7.09M | 6.74M | 12.35M | 16.45M | |||
| Intangibles | 2.20M | 825.00K | 1.53M | 2.58M | 3.98M | |||
| Other Non-Current Assets | 0.00 | 3.00K | 0.00 | 38.00K | 32.00K | |||
| Total Non-Current Assets | 5.86M | 7.92M | 8.27M | 14.96M | 20.46M | |||
| TOTAL ASSETS | 49.27M | 116.68M | 118.90M | 121.85M | 161.66M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.64M | 1.84M | 1.75M | 1.75M | 2.60M | |||
| Accrued Expenses | N/A | 5.29M | 8.09M | 3.41M | 6.98M | |||
| Accounts Payable | 10.35M | 10.91M | 5.98M | 7.78M | 6.79M | |||
| Other Current Liabilities | 11.10M | 16.90M | 8.54M | 11.64M | 9.01M | |||
| Total Current Liabilities | 23.09M | 29.65M | 24.36M | 24.57M | 25.38M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 996.00K | 2.24M | 194.00K | 1.22M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 4.00K | N/A | 0.00 | 61.00K | 2.03M | |||
| Total Non-Current Liabilities | 1.00M | 2.24M | 194.00K | 1.28M | 2.03M | |||
| TOTAL LIABILITIES | 24.09M | 31.90M | 24.55M | 25.85M | 27.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -179.59M | -100.64M | -40.53M | -30.00K | -4.76M | |||
| Additional Paid In Capital | 84.91M | 70.27M | 30.86M | 4.05M | 47.34M | |||
| Common Shares | 119.86M | 115.16M | 104.03M | 91.98M | 91.68M | |||
| Other Shareholders' Equity | 1.00K | 1.00K | 1.00K | N/A | N/A | |||
| Shares Outstanding | 119.86M | 115.15M | 104.02M | 91.98M | 75.94M | |||
| Tangible Book Value per Share | 0.19 | 0.73 | 0.89 | 1.02 | 1.72 | |||
| Total Shareholders' Equity | 25.18M | 84.78M | 94.35M | 96.00M | 134.25M | |||
| TOTAL LIABILITIES AND EQUITY | 49.27M | 116.68M | 118.90M | 121.85M | 161.66M | |||
| Statistics | ||||||||
| Debt/Equity | 0.04 | 0.03 | 0.00 | 0.01 | N/A | |||
| Current Ratio | 1.88 | 3.67 | 4.54 | 4.35 | 5.56 | |||
| Return On Assets (ROA) | -163.43% | -64.37% | -55.28% | -38.02% | -37.12% | |||
| Return On Equity (ROE) | -319.75% | -88.58% | -69.67% | -48.26% | -44.70% | |||
All data in NOK , ROIC based on taxRate of 0.23